Case report: Musculoskeletal metastastic inflammatory myofibroblastic tumor (IMT) treated by sequential ALK-TKI with longterm response

Case report: Musculoskeletal metastastic inflammatory myofibroblastic tumor (IMT) treated by sequential ALK-TKI with longterm response

Inflammatory myofibroblastic tumors (IMTs) are known to be associated with rearrangements of the anaplastic lymphoma kinase (ALK) gene. The treatment of this type of tumor includes systemic therapies such as chemotherapies or anti-inflammatories; in recent years, targeted anti-ALK therapies have eme...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thomas Cochin, Sabine Noal, Dinu Stefan, Damien Bodet, Jérémie Rouger, Marine Dorbeau, Zoé Neviere
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	inflammatory myofibroblastic tumor crizotinib sequential treatment ALK-TKI pediatric ALK inhibitor
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1505257/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer
by: Zihua Zou, et al.
Published: (2025-01-01)

Surgical treatment of uterine inflammatory myofibroblastic tumor with local invasion: A case report
by: Dan Mu, et al.
Published: (2025-02-01)

Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review
by: Mingyue Wang, et al.
Published: (2025-02-01)

Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada
by: Lara Chayab, et al.
Published: (2024-12-01)

Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
by: Seema Chugh, et al.
Published: (2025-02-01)

Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report
by: Jialin Qian, et al.
Published: (2025-03-01)

Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK‐inhibitor‐induced tolerant persister cells in ALK‐fusion‐positive lung cancer
by: Koh Furugaki, et al.
Published: (2025-02-01)

A 4-year-old Boy with a Red Nodule on His Hand: A Quiz
by: Riku Ishii, et al.
Published: (2025-01-01)

Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review
by: Hongxia Wang, et al.
Published: (2025-01-01)

Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report
by: Yang Zhang, et al.
Published: (2025-01-01)

EML4‐ALK‐Positive Ovarian Cancer With Intracranial Metastasis Responds to Lorlatinib: A Case Report and Literature Review
by: Qiongqian Li, et al.
Published: (2025-01-01)

An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors
by: Russell J. Schilder, et al.
Published: (2025-03-01)

Non-classical pulmonary exacerbation in cystic fibrosis revealing ALK-Translocated lung cancer: A case report
by: Mohamad Hadhud, et al.
Published: (2025-01-01)

The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patients
by: Li Wang, et al.
Published: (2024-01-01)

Activity of alkanmonooxygenase <i>alk</i>B gene in strains of hydrocarbon-oxidizing bacteria isolated from petroleum products
by: T. N. Shapiro, et al.
Published: (2022-10-01)

Myofibroblast-derived exosomes enhance macrophages to myofibroblasts transition and kidney fibrosis
by: Wenqiang Yu, et al.
Published: (2024-12-01)

Gastrointestinal myofibroblasts: role in regulation of physiological activity and reparation of gastro-intestinal tract
by: E. F. Barinov, et al.
Published: (2010-06-01)

Pharmacovigilance imbalance analysis of VEGFR-TKI-related taste and smell disorders
by: Zhong-hua Fu, et al.
Published: (2025-01-01)

Pneumothorax during Alectinib Treatment for a Uterine Inflammatory Myofibroblastic Tumor with Lung Metastasis
by: Chang-Ting Lin, et al.
Published: (2023-04-01)

Inflammatory myofibroblastic tumors of the urinary bladder in a 10-year-old male
by: Chen Gong, et al.
Published: (2025-02-01)

Inflammatory myofibroblastic tumor of the right renal pelvis: A case report
by: Xiaorui Zhu, et al.
Published: (2025-03-01)

Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR‐mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
by: Shang‐Gin Wu, et al.
Published: (2025-01-01)

Eight patients with inflammatory myofibroblastic tumor treated with rigid bronchoscopy
by: Byeong-Ho Jeong, et al.
Published: (2025-01-01)

Enhanced myofibroblast differentiation of eMSCs in intrauterine adhesions
by: Jun Song, et al.
Published: (2025-02-01)

Giant low-grade myofibroblastic sarcoma of the male breast: case report and literature review
by: Shiwei Xiao, et al.
Published: (2025-01-01)

Case report: Ultrasound and contrast-enhanced ultrasound findings of pediatric small intestinal inflammatory myofibroblastic tumor
by: Zengmiao Xing, et al.
Published: (2025-02-01)

An Anaplastic Lymphoma Kinase-positive Inflammatory Myofibroblastic Tumor with Rapidly Acquired Resistance to First-line Anaplastic Lymphoma Kinase Inhibitor: A Case and Literature Review
by: Shu-Cheng Wu, et al.
Published: (2024-01-01)

Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China
by: Hua Zhong, et al.
Published: (2024-12-01)

Epidermal stem cell derived exosomes-induced dedifferentiation of myofibroblasts inhibits scarring via the miR-203a-3p/PIK3CA axis
by: Shixin Zhao, et al.
Published: (2025-01-01)

Iguratimod prevents renal fibrosis in unilateral ureteral obstruction model mice by suppressing M2 macrophage infiltration and macrophage–myofibroblast transition
by: Yueyuan Zhou, et al.
Published: (2024-12-01)

Exploring practical experience with different treatments in NSCLC patients with MET-deregulated: a retrospective analysis from the real world
by: Mengmeng Li, et al.
Published: (2025-01-01)

Bladder-sparing therapy in a case report of huge muscle-invasive bladder IMT treated with 1470 nm diode laser en bloc resection followed by laparoscopic partial cystectomy
by: Junhao Chu, et al.
Published: (2025-02-01)

An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor
by: Sanjivini V. Jacob, et al.
Published: (2014-01-01)

Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma
by: Jeannette C. Oosterwijk-Wakka, et al.
Published: (2025-02-01)

REPEATED THERAPEUTIC LEUKAPHERESIS - A SOLE TREATMENT DURING PREGNANCY AS A BRIDGE BEFORE TYROSINE KINASE INHIBITORS FOR A PREGNANT WOMAN WITH CHRONIC MYELOGENOUS LEUKEMIA – A CASE REPORT AND DISCUSSION
by: Ivan Tonev, et al.
Published: (2025-01-01)

Sağlık Hizmetlerinde Kalite Tam Olarak Ne Demek?-What Actually Is Quality In Healthcare?
by: Aygen Oksay
Published: (2016-04-01)

Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production
by: Brandon R. Scharpf, et al.
Published: (2025-01-01)

Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability
by: Huiling Su, et al.
Published: (2025-02-01)

EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis
by: Ao Liu, et al.
Published: (2024-11-01)

Does longtermism depend on questionable forms of aggregation?
by: Marina Moreno
Published: (2023-03-01)